Skip to main content
Peptide Daily.
Research desk

A peptide news feed that treats sources with respect

We keep the stream editorial and source-first: regulatory updates, clinical developments, and research headlines, without mixing them into sales-y ticker copy.

FDARegulatory

FDA Issues Guidance on Peptide Drug Substance Nomenclature for INDs

New FDA guidance clarifies naming conventions and characterisation requirements for peptide drug substances in Investigational New Drug applications, aiming to reduce application deficiencies and streamline the review process for peptide-based therapeutics.

Mar 14, 2026Mar 14, 2026
regulatoryresearch